Ivím Health vs Henry Meds
$199/mo against $449/mo for tirzepatide. Which is worth it, and for whom.
Updated 2026-09-18
Both sell tirzepatide. Ivím Health costs $199 a month and Henry Meds costs $449, a difference of $250 a month or about $3,000 a year. The desk reads it as follows.
Ivím Health is unlimited clinician access. Henry Meds is sublingual and oral formats. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.
Advert against bill. Ivím Health advertises $199 and bills $199; Henry Meds advertises $399 and bills $449. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.
Side by side
| Ivím | Henry Meds | |
|---|---|---|
| Advertised | $199 | $399 |
| Billed | $199 | $449 |
| Gap | none | +$50 |
| Per year, billed | $2,388 | $5,388 |
Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.
The split
1 differences on the record. The others match.
| Ivím | Henry Meds | |
|---|---|---|
| Offers an oral or sublingual option | No | Yes |
What each puts on the record: Ivím Health
- Includes holistic coaching, wellness masterclasses and a tracking app.
- New patients are offered a complimentary 30-minute consultation.
Where it wins: Unlimited clinician visits at a flat rate — unusual at this price. Watch for: Pharmacy sourcing is not published. Ask which pharmacy fills your prescription and whether it is 503A or 503B before starting.
What each puts on the record: Henry Meds
- Three-month oral tirzepatide supply $1,047, or $891 paid in full.
- Three-month oral semaglutide supply $747, or $537 paid in full.
Where it wins: No membership fee layered on top of medication. Watch for: The advertised "starts at $179" is the sublingual tier. Weekly injectable tirzepatide renews at $449/month.
In each one’s favour
Ivím Health.
- Unlimited clinician visits at a flat rate — unusual at this price.
- Weekly dose review rather than a fixed monthly escalation.
Henry Meds.
- No membership fee layered on top of medication.
- Real choice of sublingual, oral tablet and injection.
Ivím Health scores higher overall at 4 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.
The desk’s call
The board says Ivím Health. What the board cannot say is whether the advertised figures you were shown elsewhere match these — check the gap row, because a listing that advertises low and bills high will beat an honest one in any comparison built on advertised prices.
The verdict
On the board, Ivím Health at $199 a month is the more defensible choice on arithmetic alone. Henry Meds earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Ivím Health and Henry Meds.
How they sit against everyone else
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
More from the desk
- Ivím Health tirzepatide review
Advertised at $199 and billed at $199 — no gap. Position 6 of 18 on our board.
- Henry Meds tirzepatide review
Advertised at $399, billed at $449. Position 18 of 18 on our board.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- The twelve-month cost
Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure
